Novo Nordisk A/S Release: Transaction in Own Shares

BAGSVÆRD, DENMARK--(Marketwire - December 22, 2008) - Novo Nordisk A/S - Share repurchase programme

On 15 August 2008 Novo Nordisk initiated its share repurchase programme in accordance with the provisions of the European Commission's regulation no 2273/2003 of 22 December 2003, also referred to as the Safe Harbour rules.

Under the programme Novo Nordisk will repurchase B shares for an amount of up to DKK 1.7 billion in the period from 15 August 2008 to 19 December 2008. The programme thereby ended on 19 December 2008.

Since the announcement as of 15 December 2008, the following transactions have been made under the programme:

                  Number of    Average      Transaction
                   shares   purchase price  value, DKK
Accumulated, last
announcement      5,399,000                1,542,096,704
15 December 2008    110,000    283.2200       31,154,200
16 December 2008    120,000    278.9400       33,472,800
17 December 2008    115,000    278.1100       31,982,650
18 December 2008    110,000    277.7700       30,554,700
19 December 2008    108,500    282.9700       30,702,245
Accumulated under
the programme     5,962,500                1,699,963,299

With the transactions stated above, Novo Nordisk owns a total of 25,721,095 treasury shares, corresponding to 4.1% of the share capital. The total amount of shares in the company is 634,000,000 including treasury shares.

Novo Nordisk is a healthcare company and a world leader in diabetes care. In addition, Novo Nordisk has a leading position within areas such as haemostasis management, growth hormone therapy and hormone replacement therapy. Novo Nordisk manufactures and markets pharmaceutical products and services that make a significant difference to patients, the medical profession and society. With headquarters in Denmark, Novo Nordisk employs approximately 26,550 employees in 80 countries, and markets its products in 179 countries. Novo Nordisk's B shares are listed on the stock exchanges in Copenhagen and London. Its ADRs are listed on the New York Stock Exchange under the symbol 'NVO'. For more information, visit novonordisk.com.

Company Announcement no 82 / 2008

This announcement was originally distributed by Hugin. The issuer is solely responsible for the content of this announcement.

Copyright © Hugin AS 2008. All rights reserved.